# Preventive Effect of the PRetreatment With Intravenous Nicorandil on Contrast-Induced Nephropathy in Patients With RenaL Dysfunction UndEergoing Coronary Angiography (PRINCIPLE Study)

Study · id `cardio:ct-nct01103336` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01103336](<https://clinicaltrials.gov/study/NCT01103336>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01103336

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 173 participants.

## Technical summary

Registry record NCT01103336. Randomized; no masking; primary purpose prevention. Start 2010-03 (registry gives no type); primary completion 2011-06 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 173 participants (enrolled count; ClinicalTrials.gov record NCT01103336, source copy `cardio:ctgov-nct01103336-2012-02-06`, retrieved 2026-10-26)
- Start date: 2010-03 (registry gives no type) (ClinicalTrials.gov record NCT01103336, source copy `cardio:ctgov-nct01103336-2012-02-06`, retrieved 2026-10-26)
- Primary completion: 2011-06 (actual) (ClinicalTrials.gov record NCT01103336, source copy `cardio:ctgov-nct01103336-2012-02-06`, retrieved 2026-10-26)
- Completion: 2011-06 (actual) (ClinicalTrials.gov record NCT01103336, source copy `cardio:ctgov-nct01103336-2012-02-06`, retrieved 2026-10-26)
- Countries: South Korea (ClinicalTrials.gov record NCT01103336, source copy `cardio:ctgov-nct01103336-2012-02-06`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01103336-2012-02-06`, retrieved 2026-10-26)

## The registry's words

- Brief title: Preventive Effect of the PRetreatment With Intravenous Nicorandil on Contrast-Induced Nephropathy in Patients With RenaL Dysfunction UndEergoing Coronary Angiography (PRINCIPLE Study)
- Condition: Chronic Renal Failure
- Intervention (Drug): pretreatment with intravenous nicorandil vs. placebo before coronary angiography
- Lead sponsor: Yonsei University
- Lead sponsor class: OTHER
- Collaborator: GE Healthcare
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry lists this organization as the lead sponsor: Yonsei University (`cardio:org-yonsei-university`)
- Registry lists this organization as a collaborator: GE Healthcare (`cardio:org-ge-healthcare`)

## Provenance

Content hash: d3c208958b5998e5efd260bad548e709b614b240862997d22ead6cd9011d3270
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
